Waon therapy improves quality of life as well as cardiac function and exercise capacity in patients with chronic heart failure

International Heart Journal

Volumn 56, Issue 2, 2015, Pages 203-208

  Sobajima, Mitsuo ^a   Nozawa, Takashi ^a   Fukui, Yasutaka ^a   Ihori, Hiroyuki ^a   Ohori, Takashi ^a   Fujii, Nozomu ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Flow mediated dilation; Natural killer cell; Sauna; SF 36

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTERY DILATATION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFRARED RADIATION; INTERVIEW; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; SAUNA; SCORING SYSTEM; SHORT FORM 36; BLOOD; CHRONIC DISEASE; EXERCISE TOLERANCE; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; VASCULAR ENDOTHELIUM; VASODILATATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; QUALITY OF LIFE; STEAM BATH; STROKE VOLUME; VASODILATION;

EID: 84929941375     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-266     Document Type: Article

References (34)

1. Kihara T, Miyata M, Fukudome T, et al. Waon therapy improves the prognosis of patients with chronic heart failure. J Cardiol 2009; 53: 214-8.
2. Miyata M, Tei C. Waon therapy for cardiovascular disease: inno-vative therapy for the 21st century. Circ J 2010; 74: 617-21. (Review).
3. Ohori T, Nozawa T, Ihori H, et al. Effect of repeated sauna treat-ment on exercise tolerance and endothelial function in patients with chronic heart failure. Am J Cardiol 2012; 109: 100-4.
4. Kihara T, Biro S, Imamura M, et al. Repeated sauna treatment im-proves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 754-9.
5. Sobajima M, Nozawa T, Shida T, et al. Repeated sauna therapy at-tenuates ventricular remodeling after myocardial infarction in rats by increasing coronary vascularity of noninfarcted myocardium. Am J Physiol Heart Circ Physiol 2011; 301: H548-54.
6. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunc-tion on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002; 23: 1867-76.
7. Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of de-pression to death or hospitalization in patients with heart failure. Arch Intern Med 2007; 167: 367-73.
8. Rumsfeld JS, Havranek E, Masoudi FA, et al; Cardiovascular Out-comes Research Consortium. Depressive symptoms are the strongest predictors of short-term declines in health status in pa-tients with heart failure. J Am Coll Cardiol 2003; 42: 1811-7.
9. Xu SD, Su GH, Lu YX, et al. Elevated soluble ST2 and depres-sion increase the risk of all-cause mortality and hospitalization in patients with heart failure. Int Heart J 2014; 55: 445-50.
10. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987; 316: 1429-35.
11. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation 1994; 90: 1765-73.
12. Mori Y, Nishikawa Y, Kobayashi F, Hiramatsu K. Clinical status and outcome of Japanese heart failure patients with reduced or preserved ejection fraction treated with carvedilol. Int Heart J 2013; 54: 15-22.
13. Wolfel EE. Effects of ACE inhibitor therapy on quality of life in patients with heart failure. Pharmacology 1998; 18: 1323-34. (Review).
14. Reddy P, Dunn AB. The effect of beta-blockers on health-related quality of life in patients with heart failure. Pharmacotherapy 2000; 20: 679-89. (Review).
15. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024-8.
16. Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 1999; 137: 453-7.
17. Hughes JW, Watkins L, Blumenthal JA, Kuhn C, Sherwood A. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res 2004; 57: 353-8.
18. Kuwahata S, Miyata M, Fujita S, et al. Improvement of autonomic nervous activity by Waon therapy in patients with chronic heart failure. J Cardiol 2011; 57: 100-6.
19. Glaser EM, Shephard RJ. Simultaneous experimental acclimatiza-tion to heart and cold in man. J Physiol 1963; 169: 592-602.
20. Kubota K, Kurabayashi H, Tamura K, Kawada E, Tamura J, Shirakura T. A transient rise in plasma beta-endorphin after a tra-ditional 47 degrees C hot-spring bath in Kusatsu-spa, Japan. Life Sci 1992; 51: 1877-80.
21. Vescovi PP, Gerra G, Pioli G, Pedrazzoni M, Maninetti L, Passeri M. Circulating opioid peptides during thermal stress. Horm Metab Res 1990; 22: 44-6.
22. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative re-producibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circu-lation 1981; 64: 1227-34.
23. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Ja-pan. J Clin Epidemiol 1998; 51: 1037-44.
24. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short- Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medi-cal Care 1993; 31: 247-63.
25. Zuluaga MC, Guallar-Castillón P, López-García E, et al. Generic and disease-specific quality of life as a predictor of long-term mortality in heart failure. Eur J Heart Fail 2010; 12: 1372-8.
26. Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol 1996; 78: 890-5.
27. Rogers WJ, Johnstone DE, Yusuf S, et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized be-tween placebo and enalapril: the Studies of Left Ventricular Dys-function. The SOLVD Investigators. J Am Coll Cardiol 1994; 23: 393-400.
28. Gundersen T, Wiklund I, Swedberg K, Amtorp O, Remes J, Nils-son B. Effects of 12 weeks of ramipril treatment on the quality of life in patients with moderate congestive heart failure: results of a placebo-controlled trial. Ramipril Study Group. Cardiovasc Drugs Ther 1995; 9: 589-94.
29. Jenkinson C, Jenkinson D, Shepperd S, Layte R, Petersen S. Eval-uation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing 1997; 26: 7-13.
30. De Marco T, Wolfel E, Feldman AM, et al. Impact of cardiac re-synchronization therapy on exercise performance, functional ca-pacity, and quality of life in systolic heart failure with QRS pro-longation: COMPANION trial sub-study. J Card Fail 2008; 14: 9-18.
31. Masuda A, Nakazato M, Kihara T, Minagoe S, Tei C. Repeated thermal therapy diminishes appetite loss and subjective complaints in mildly depressed patients. Psychosom Med 2005; 67: 643-7.
32. Saeki Y, Nagai N, Hishinuma M. Effects of footbathing on auto-nomic nerve and immune function. Complement Ther Clin Pract 2007; 13: 158-65.
33. Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M. Noc- turnal catecholamines and immune function in insomniacs, de-pressed patients, and control subjects. Brain Behav immune 2003; 17: 365-72.
34. Tei C. Waon therapy: soothing warmth therapy. J Cardiol 2007; 49: 301-4.